Profile

Cover photo
Amarantus BioScience, Inc.
16 followers|4,514 views
AboutPostsPhotosVideos

Stream

 
Amarantus to host investor update conference call today 4:05pm ET. Participants will include President & CEO Gerald Commissiong, Dr. David Lowe and Bob Farrell, CFO. See dial-in information here: http://bit.ly/1r8uzA0
1
Add a comment...
 
Amarantus reported financial results and development progress for the year ended December 31, 2013. The Company will host a conference call on Thursday, April 24th at 4:05pm ET to provide updates and address investor questions. CEO Gerald Commissiong states, "2013 was an important year for Amarantus as we improved our balance sheet substantially, and laid the groundwork for significant growth in 2014." http://bit.ly/1r8uzA0
1
Add a comment...
 
Twelve year old Devin Kerby is living daily with the effects of TBI from a major car crash she suffered at just 4 years old. Today, she does all she can to raise money for this "silent epidemic." http://bit.ly/OfeTfI
FLORENCE, Ala. (WHNT) - It's called the Silent Epidemic. Each year 100,000 people die from Traumatic Brain Injury, and 500,000 more are permanently disabled. But one young girl from Florence, livin...
1
Add a comment...
 
More than 5.4 million Americans are living with Alzheimer’s disease, and a new report by the Alzheimer’s Association shows women are hit especially hard. Women after the age of 60 are more likely to develop Alzheimer's than breast cancer, they are also at the "at the epicenter of caregiving for someone with Alzheimer’s.” Angela Geiger, Chief Strategy Officer of the Alzheimer’s Association hopes this report will help move Alzheimer's treatment to center stage. http://onforb.es/1j4OQ6n
They're more likely to get the disease and care for someone from it.
1
Add a comment...
 
Follow our LinkedIn page and join today’s conversation on the LymPro Test. https://www.linkedin.com/company/amarantus-biosciences
1
Add a comment...
Have them in circles
16 people
 
Vote for Amarantus as your 'favorite innovative biotech company' in the 'Pipelines of Promise and Technologies of Tomorrow' category! Voting ends April 22nd, winners to be announced April 24th. http://bit.ly/1p7qcaY
1
Add a comment...
 
Apple is now highlighting how its tablet can be used for more than just entertainment and content consumption. The company is now advertising "C3 Logix," an app designed to measure the health of athletes after a concussion. http://on.mash.to/Offn5F
In a new page on Apple's website, the company is advertising C3 Logix, an iPad app designed to measure the health of athletes after a concussion.
1
Add a comment...
 
Amarantus appoints Dr. Charlotte Keywood as Chief Medical Officer of it's therapeutics division. Dr. Keywood brings over 20 years of experience in the biopharmaceutical drug development industry. CEO Gerald Commissiong states "We believe this experience will be of great value to Amarantus as we prepare to continue the development of Eltoprazine into Phase 2b clinical trials." http://bit.ly/PYImvv
1
Add a comment...
 
"I used to be the athlete," said Allison Kasacavage. "Now I'm the girl with concussions." Kasacavage, 17, suffers daily with the aftereffects of concussions from soccer. Christina L. Master, a sports-medicine specialist and concussion researcher at the Children's Hospital of Philadelphia always believed young athletes recovered quickly from a concussion; she is now seeing this is not the case; and something needs to be done. http://bit.ly/1j4Nato
Hannah Thomas, 17, can't pinpoint the day she realized that she would never play soccer again, or when the teenage highs of proms and college acceptances became weighed down by meds, therapy, and...
1
Add a comment...
 
Amarantus appoints Robert Farrell J.D. as Chief Financial Officer; bringing over 20 years of healthcare, public company and CFO experience to the Company. "We expect 2014 to be a transformative year for Amarantus as we lay the groundwork for long-term shareholder value creation," states Mr. Farrell. http://bit.ly/1olB58Q
1
Add a comment...
Story
Introduction
Amarantus BioSciences, Inc. is developing new treatments for Parkinson's and Traumatic Brain Injury.